Hodgkin's disease and anaplastic large cell lymphoma revisited II. From cytokines to cell lineage

Journal of Biomedical Science

Volumn 3, Issue 1, 1996, Pages 1-13

  Hsu, Su Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cytokine; Hodgkin's disease; Lymphoma

Indexed keywords

CYTOKINE;

B CELL LYMPHOMA; HODGKIN DISEASE; HUMAN; LYMPHOMA CELL LINE; LYMPHOPOIESIS; PRIORITY JOURNAL; REED STERNBERG CELL; REVIEW; T CELL LYMPHOMA;

PHRAGMITES;

EID: 0030020614     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/bf02253573     Document Type: Article

References (22)

1. al Saati T, Delecluze HJ, Chittal S, Brousset P, Magaud JP, Dastugue N, Cohen-Knafo E, Laurent G, Rubin B, Delsol G. A novel human lymphoma cell line (Deglis) with dual B/T phenotype and gene rearrangements and containing Epstein-Barr virus genomes. Blood 80:209-216;1992.
2. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, Somoza C. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 336:76-79;1993.
3. Azuma M, Yssel H, Phillips JH, Spits H, Lanier LL. Functional expression of B7/BBI on activated T lymphocytes. J Exp Med 177:845-850;1993.
4. Banchereau J, Rousset F. Human B lymphocytes: property, proliferation, and differentiation. Adv Immunol 52:135-262;1992.
5. Banks PM, Metter J, Allred DC. Anaplastic large cell (Ki-1) lymphoma with histiocytic phenotype simulating carcinoma. Am J Clin Pathol 94:445-452;1990.
6. Barberis A, Eidenhorn K, Vitelli L, Busslinger M. A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation. Genes Dev 4:849-859;1990.
7. Bargou RC, Mapara MY, Zugck C, Daniel PT, Pawlita M, Dohner H, Dorken B. Characterization of a novel Hodgkin cell line, HD-Myz, with myelomonocytic features mimicking Hodgkin's disease in severe combined immunodeficient mice. J Exp Med 177:1257-1268;1993.
8. Bender JG, Unverzagt KL, Walker DE, Lee W, Van Epps DE, Smith DH, Stewart CC, To LB. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 77:2591-2596;1991.
9. Benjamin D, Sharma V, Knobloch TJ, Armitage RJ, Dayton MA, Goodwin RG. B cell IL-7: Human B cell lines constituively secrete IL-7 and express IL-7 receptors. J Immunol 152:4749-4757;1994.
10. Bitter MA, Franklin WA, Larson RA, McKeithan TW, Rubin CM, Le Beau MM, Stephens JK, Vardiman JW. Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol 14:305-316;1990.
11. Borowitz MJ, Shuster JJ, Civin CI, Carroll AJ, Look AT, Behm FG, Land VJ, Pullen DJ, Crist WM. Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a pediatric oncology group study. J Clin Oncol 8:1389-1398;1990.
12. Bowen MA, Olsen KJ, Cheng L, Avila D, Podack ER. Functional effects of CD30 on a large granlar lymphoma cell line, YT: Inhibition of cytotoxicity, regulation of CD28 and IL-2R, and induction of homotypic aggregation. J Immunol 151:5896-5906;1993.
13. Branch MA, Burhing HJ, Grub HG, Ashman LK, Ludwig WF, Mertelsmann RH, Herrmann F. Functional expression of c-kit by acute myelogenous leukemia blasts is enhanced by tumor necrosis factor-α through posttranscriptional mRNA stabilization by a labile protein. Blood 80:1224-1230;1992.
14. Braylan RC, Jaffe ES, Berard CW. Malignant lymphomas: Current classification and new observations. Pathol Annual 10:213-270;1975.
15. Broxmeyer He, Maze R, Miyazawa K, Carow C, Hendrie PC, Coopers S, Hangoc G, Vadhan-Ray S, Lu L. The kit receptor and its ligand, steel factor, as regulators of hemopoiesis. Cancer Cells 3:480-487;1991.
16. Buckley PJ, O'Laughlin S, Komp DM. Histiocytes in familial and infection-induced/idiopathic hemophagocytic syndromes may exhibit phenotypic differences. Pediatr Pathol 12:51-66;1992.
17. c-kit) is a human bone marrow surface antigen of hematopoietic precursorc cells which is expressed on a subset of acute non-lymphoblastic leukemic cells. Leukemia 5:854-860;1991.
18. Byrne GE Jr, Rappaport H. Malignant histiocytosis. Gann Mono Cancer Res 15:145-162;1973.
19. Carbone A, Gloghini A, De Re V, Tamaro P, Boiocchi M, Volpe R. Histopathologic, immunophenotypic, and genotypic analysis of Ki-1 anaplastic large cell lymphomas that express histiocyte-associated antigens. Cancer 66:2547-2556;1990.
20. Carbone A, Gloghini A, Gattei V, Aldinucci D, Degan M, De Paoli P, Zagonel V, Pinto A. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood 85:780-789;1995.
21. Carbone A, Gloghini A, Volpe R. Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell lymphoma (CD30+) lymphomas. Virchows Arch [A] 420:527-532;1992.
22. Carbone A, Gloghini A, Volpe R, Pinto A. KP1 (CD68)-positive large cell lymphoma: A histopathologic and immunophenotypic characterization of 12 cases. Hum Pathol 24:886-896;1993.